ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.
- Revenue
- +5.93%
- EPS
- +23.1%
- Free cash flow
- −9.79%
- Total debt
- −38.9%
Quarter to September 2026, against a year earlier
Follow RMD
Alert me
ResMed Inc. (RMD) P/E ratio
As of 5 November 2026, ResMed Inc. (RMD) trades at a P/E ratio of 21.7×. Over the past ten years it has ranged from 17.6× (June 2026) to 90.9× (September 2021); the current reading is higher than 6% of that period. That is below the Medical Instruments & Supplies industry median of 30.3× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 18.6× | (31.04%) |
| FY2025 | 27.0× | 0.29% |
| FY2024 | 26.9× | (24.68%) |
| FY2023 | 35.8× | (9.07%) |
| FY2022 | 39.3× | (47.83%) |
| FY2021 | 75.4× | 69.23% |
| FY2020 | 44.5× | 1.87% |
| FY2019 | 43.7× | (6.45%) |
| FY2018 | 46.7× | 45.28% |
| FY2017 | 32.2× | 24.17% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 20.1× | 7.79% |
| Jun 2026 | 18.6× | (13.68%) |
| Mar 2026 | 21.6× | (9.04%) |
| Dec 2025 | 23.7× | (14.95%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BAX Baxter International Inc. compare | n/m |
| COO The Cooper Companies, Inc. compare | 21.7× |
| RMD ResMed Inc. | 21.7× |
| ALGN Align Technology, Inc. compare | 23.1× |
| WST West Pharmaceutical Services, Inc. compare | 43.8× |
| ALC Alcon compare | 58.4× |
| MDLN Medline Inc. compare | 58.4× |
| BDX Becton, Dickinson and Company compare | 64.1× |
| SOLV Solventum Corporation compare | 97.3× |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement